Difficulty: Medium
Average Score: 63%
Practice
Regarding non-depolarizing muscle relaxants
Correct answer
A
Rationale
The correct answer is A) Pancuronium is eliminated via the kidney.
Pancuronium is a non-depolarizing muscle relaxant that is primarily eliminated through renal excretion. This is an important pharmacokinetic characteristic to consider when administering the drug, especially in patients with renal impairment. Understanding the elimination pathway of a medication is crucial for determining dosing adjustments and avoiding potential drug accumulation and toxicity.
Option B) Rocuronium is an isoquinolone derivative is incorrect because rocuronium belongs to the aminosteroid class of non-depolarizing muscle relaxants, not isoquinolone derivatives. This is a common misconception that can be clarified through a deeper understanding of drug classifications.
Option C) Rocuronium undergoes Hoffman elimination is incorrect because rocuronium undergoes hepatic metabolism, primarily through organ-independent Hofmann elimination. Understanding the metabolic pathways of drugs is essential for predicting drug interactions and potential adverse effects.
Option D) Vecuronium is eliminated predominantly via the kidney is incorrect because vecuronium is primarily metabolized in the liver and excreted via biliary elimination. Knowing the predominant elimination route of a drug is crucial for determining its pharmacokinetic profile and potential interactions with other medications.
In the context of CNS drugs pharmacology, understanding the pharmacokinetic properties of muscle relaxants is essential for safe and effective patient care. By grasping how these drugs are metabolized and eliminated, healthcare professionals can make informed decisions regarding dosing, monitoring, and patient management.
Pancuronium is a non-depolarizing muscle relaxant that is primarily eliminated through renal excretion. This is an important pharmacokinetic characteristic to consider when administering the drug, especially in patients with renal impairment. Understanding the elimination pathway of a medication is crucial for determining dosing adjustments and avoiding potential drug accumulation and toxicity.
Option B) Rocuronium is an isoquinolone derivative is incorrect because rocuronium belongs to the aminosteroid class of non-depolarizing muscle relaxants, not isoquinolone derivatives. This is a common misconception that can be clarified through a deeper understanding of drug classifications.
Option C) Rocuronium undergoes Hoffman elimination is incorrect because rocuronium undergoes hepatic metabolism, primarily through organ-independent Hofmann elimination. Understanding the metabolic pathways of drugs is essential for predicting drug interactions and potential adverse effects.
Option D) Vecuronium is eliminated predominantly via the kidney is incorrect because vecuronium is primarily metabolized in the liver and excreted via biliary elimination. Knowing the predominant elimination route of a drug is crucial for determining its pharmacokinetic profile and potential interactions with other medications.
In the context of CNS drugs pharmacology, understanding the pharmacokinetic properties of muscle relaxants is essential for safe and effective patient care. By grasping how these drugs are metabolized and eliminated, healthcare professionals can make informed decisions regarding dosing, monitoring, and patient management.